Status:

COMPLETED

Association Between Genetic Algorithm to Predict Hypertension Therapy and Response to Treatment

Lead Sponsor:

Geneticure, LLC

Collaborating Sponsors:

Fairview Health Services

Conditions:

Hypertension

Eligibility:

All Genders

30-80 years

Brief Summary

To assess the effectiveness of the use of a patient's genes to predict which hypertension therapy is successful

Detailed Description

Hypertension is known to have a strong heritable component. Previous work has demonstrated that sons of hypertensive patients are more likely to be hypertensive when compared to sons of normotensive i...

Eligibility Criteria

Inclusion

  • Subject is able and willing to provide informed consent
  • Subject is ≥ 20 and ≤ 85 years of age
  • Subject with diagnosis of Hypertension for a minimum of 1 year
  • Subject has been on the same class/classes of blood pressure medication for a minimum of 6 months. Note: A change in dosage, frequency, or specific medication is acceptable as long as there have been no changes to the class/classes of medications prescribed.
  • Subject with a Body Mass Index (BMI) ≥ 19 and ≤ 45
  • Subject is currently prescribed and taking one of the following classes of medications alone or in combination with each other.
  • Diuretics (thiazide or thiazide-like)
  • ACE Inhibitors
  • Angiotensin Receptor Blocker (ARB)
  • Beta-blockers
  • Ca+ Channel Blockers

Exclusion

  • Subject has a diagnosis of secondary hypertension or is experiencing a complication of pregnancy.
  • Subject is currently prescribed and taking any additional class of medication(s) for high blood pressure not included in the list above
  • Subject has Systolic BP \> 190 or Diastolic BP \> 120 documented within the six months prior to visit.
  • Any other reason that the subject is inappropriate for study enrollment in the opinion of the Investigator.

Key Trial Info

Start Date :

March 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 15 2019

Estimated Enrollment :

758 Patients enrolled

Trial Details

Trial ID

NCT03292900

Start Date

March 1 2018

End Date

January 15 2019

Last Update

February 15 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fairview Clinic - New Brighton

New Brighton, Minnesota, United States, 55112